DLX3 and tricho-dento-osseous syndrome: In this TDO patient, DLX3 (Q178R) mutation results in lower levels of expression of RUNX2, OCN, ALP, BMP2, p16INK4a, p53, p21, and so on, decreases osteogenesis and senescence.